Picture of Innovative Pharmaceutical Biotech logo

399 Innovative Pharmaceutical Biotech Cashflow Statement

0.000.00%
hk flag iconLast trade - 00:00
IndustrialsAdventurousMicro CapSucker Stock

Annual cashflow statement for Innovative Pharmaceutical Biotech, fiscal year end - March 31st, HKD millions except per share, conversion factor applied.

2020
March 31st
2021
March 31st
2022
March 31st
2023
March 31st
2024
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
HKAS
HKAS
HKAS
HKAS
HKAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-222-21236.4-25598.7
Depreciation
Non-Cash Items190191-60.8234-112
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-5.16-69.881.364.28
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-36.2-25-12.3-17.6-8.28
Other Investing Cash Flow Items500.013-0.00100
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Other Investing Cash Flow
Cash from Investing Activities500.013-0.00100
Financing Cash Flow Items-0.116-0.127-0.0845.8-0.011
Other Financing Cash Flow
Net Issuance / Retirement of Debt
Cash from Financing Activities-9.4810.67.314.910.3
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash5.88-13.9-4.91-2.751.74